Cargando…
Essential Oils and Neuropathic Pain
Neuropathic pain is one of the most prominent chronic pain syndromes, affecting almost 10% of the United States population. While there are a variety of established pharmacologic and non-pharmacologic treatment options, including tricyclic antidepressants (TCAs), serotonin-noradrenaline reuptake inh...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323890/ https://www.ncbi.nlm.nih.gov/pubmed/35890431 http://dx.doi.org/10.3390/plants11141797 |
_version_ | 1784756669276749824 |
---|---|
author | Ridouh, Imane Hackshaw, Kevin V. |
author_facet | Ridouh, Imane Hackshaw, Kevin V. |
author_sort | Ridouh, Imane |
collection | PubMed |
description | Neuropathic pain is one of the most prominent chronic pain syndromes, affecting almost 10% of the United States population. While there are a variety of established pharmacologic and non-pharmacologic treatment options, including tricyclic antidepressants (TCAs), serotonin-noradrenaline reuptake inhibitors, anticonvulsants, trigger point injections, and spinal cord stimulators, many patients continue to have chronic pain or suboptimal symptom control. This has led to an increased interest in alternative solutions for neuropathic pain such as nutritional supplements and essential oils. In this review, we explore the literature on the most commonly cited essential oils, including lavender, bergamot, rosemary, nutmeg, Billy goat weed, and eucalyptus. However, the literature is limited and largely comprised of preclinical animal models and a few experimental studies, some of which were poorly designed and did not clearly isolate the effects of the essential oil treatment. Additionally, no standardized method of dosing or route of administration has been established. Further randomized control studies isolating the active components of various essential oils are needed to provide conclusive evidence on the use of essential oils for neuropathic pain. In this review, we explore the basis behind some of the essential oils of interest to patients with neuropathic pain seen in rheumatology clinics. |
format | Online Article Text |
id | pubmed-9323890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93238902022-07-27 Essential Oils and Neuropathic Pain Ridouh, Imane Hackshaw, Kevin V. Plants (Basel) Review Neuropathic pain is one of the most prominent chronic pain syndromes, affecting almost 10% of the United States population. While there are a variety of established pharmacologic and non-pharmacologic treatment options, including tricyclic antidepressants (TCAs), serotonin-noradrenaline reuptake inhibitors, anticonvulsants, trigger point injections, and spinal cord stimulators, many patients continue to have chronic pain or suboptimal symptom control. This has led to an increased interest in alternative solutions for neuropathic pain such as nutritional supplements and essential oils. In this review, we explore the literature on the most commonly cited essential oils, including lavender, bergamot, rosemary, nutmeg, Billy goat weed, and eucalyptus. However, the literature is limited and largely comprised of preclinical animal models and a few experimental studies, some of which were poorly designed and did not clearly isolate the effects of the essential oil treatment. Additionally, no standardized method of dosing or route of administration has been established. Further randomized control studies isolating the active components of various essential oils are needed to provide conclusive evidence on the use of essential oils for neuropathic pain. In this review, we explore the basis behind some of the essential oils of interest to patients with neuropathic pain seen in rheumatology clinics. MDPI 2022-07-07 /pmc/articles/PMC9323890/ /pubmed/35890431 http://dx.doi.org/10.3390/plants11141797 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ridouh, Imane Hackshaw, Kevin V. Essential Oils and Neuropathic Pain |
title | Essential Oils and Neuropathic Pain |
title_full | Essential Oils and Neuropathic Pain |
title_fullStr | Essential Oils and Neuropathic Pain |
title_full_unstemmed | Essential Oils and Neuropathic Pain |
title_short | Essential Oils and Neuropathic Pain |
title_sort | essential oils and neuropathic pain |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323890/ https://www.ncbi.nlm.nih.gov/pubmed/35890431 http://dx.doi.org/10.3390/plants11141797 |
work_keys_str_mv | AT ridouhimane essentialoilsandneuropathicpain AT hackshawkevinv essentialoilsandneuropathicpain |